Cited by 207Alzheimer's disease research and treatmentsExtracellular vesicles in diseaseDementia and Cognitive Impairment Research

The DOI matches its Crossref record; 28 of the 29 references it cites were found in a registry or an index.

CNS tau efflux via exosomes is likely increased in Parkinson's disease but not in Alzheimer's disease

Open access

Shi, Min, Kovac, Andrej, Korff, Ane, Cook, Travis J., Ginghina, Carmen, Bullock, Kristin M., Yang, Li, Stewart, Tessandra, Zheng, Danfeng, Aro, Patrick, Atik, Anzari, Kerr, Kathleen F., Zabetian, Cyrus P., Peskind, Elaine R., Hu, Shu‐Ching, Quinn, Joseph F., Galasko, Douglas R., Montine, Thomas J., Banks, William A., Zhang, Jing·2016·Alzheimer's & Dementia

DOI 10.1016/j.jalz.2016.04.003PMC PMC5107127

Open this paper in CoChat — free account

Abstract

Introduction: Alzheimer's disease (AD) and Parkinson's disease (PD) involve tau pathology. Tau is detectable in blood, but its clearance from neuronal cells and the brain is poorly understood. Methods: Tau efflux from the brain to the blood was evaluated by administering radioactively labeled and unlabeled tau intracerebroventricularly in wild‐type and tau knock‐out mice, respectively. Central nervous system (CNS)–derived tau in L1CAM‐containing exosomes was further characterized extensively in human plasma, including by single molecule array technology with 303 subjects. Results: The efflux of Tau, including a fraction via CNS‐derived L1CAM exosomes, was observed in mice. In human plasma, tau was explicitly identified within L1CAM exosomes. In contrast to AD patients, L1CAM exosomal tau was significantly higher in PD patients than controls and correlated with cerebrospinal fluid tau. Conclusions: Tau is readily transported from the brain to the blood. The mechanisms of CNS tau efflux are likely different between AD and PD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.jalz.2016.04.003

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations
Rissin, D. M., Kan, C. W., Campbell, T. G., Howes, S. C., Fournier, D. R., Song, L., Piech, T., Patel, P. P., Chang, L., Rivnak, A. J., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1641 · Cited by 2,119
Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
Shaw, L. M., Vanderstichele, H., Knapik‐Czajka, M., Clark, C. M., Aisen, P. S., Petersen, R. C., Blennow, K., Soares, H., Simon, A., Lewczuk, P., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21610 · Cited by 2,065
Genome-wide association study reveals genetic risk underlying Parkinson's disease
Simón-Sánchez, J., Schulte, C., Bras, J. M., Sharma, M., Gibbs, J. R., Berg, D., Paisan-Ruiz, C., Lichtner, P., Scholz, S. W., Hernandez, D. G., et al. (2009) · Nature Genetics · doi:10.1038/ng.487 · Cited by 1,751
Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis
Dragovic, R., Gardiner, C., Brooks, A. S., Tannetta, D., Ferguson, D. J. P., Hole, P., Carr, B., Redman, C. W. G., Harris, A. L., Dobson, P. J., et al. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2011.04.003 · Cited by 1,368
Tau pathology and neurodegeneration
Spillantini, M. G., & Goedert, M. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70090-5 · Cited by 1,133
Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case‐control study
Fiandaca, M. S., Kapogiannis, D., Mapstone, M., Boxer, A., Eitan, E., Schwartz, J. B., Abner, E. L., Petersen, R. C., Federoff, H. J., Miller, B. L., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.06.008 · Cited by 959
Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson’s disease
Shi, M., Liu, C., Cook, T. J., Bullock, K. M., Zhao, Y., Ginghina, C., Li, Y., Aro, P., Dator, R., He, C., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1314-y · Cited by 676
Self-citation
DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson’s disease
Hong, Z., Shi, M., Chung, K. A., Quinn, J. F., Peskind, E. R., Galasko, D., Jankovic, J., Zabetian, C. P., Leverenz, J. B., Baird, G., et al. (2010) · Brain · doi:10.1093/brain/awq008 · Cited by 615
Self-citation
Genome‐Wide Association Study Confirms SNPs in SNCA and the MAPT Region as Common Risk Factors for Parkinson Disease
Edwards, T. L., Scott, W. K., Almonte, C., Burt, A., Powell, E. H., Beecham, G. W., Wang, L., Zuchner, S. L., Konidari, I., Wang, G., et al. (2010) · Annals of Human Genetics · doi:10.1111/j.1469-1809.2009.00560.x · Cited by 471
Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression
Shi, M. Y., Bradner, J. M., Hancock, A. M., Chung, K. A., Quinn, J. F., Peskind, E. R., Galasko, D., Jankovic, J. J., Zabetian, C. P., Kim, H. M., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22311 · Cited by 422
Self-citation

Show all 29 references

Research works printed but not linked: 1

Davson H, 1996, The return of the cerebrospinal fluid to the blood: the drainage mechanism. Physiology of the CSF and blood‐brain barriers, 489

Sorted by citations

Exosome Processing and Characterization Approaches for Research and Technology Development
Lai, J. J., Chau, Z. L., Chen, S., Hill, J. J., Korpany, K. V., Liang, N., Lin, L., Lin, Y., Liu, J. K., Liu, Y., et al. (2022) · Advanced Science · doi:10.1002/advs.202103222 · Cited by 623
Transport of Extracellular Vesicles across the Blood-Brain Barrier: Brain Pharmacokinetics and Effects of Inflammation
Banks, W. A., Sharma, P., Bullock, K. M., Hansen, K. M., Ludwig, N., & Whiteside, T. L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124407 · Cited by 561
“An efflux system would explain why CNS-derived exosomes are found in the circulation [7], raising the question of their role in disease states and supporting their usefulness as biomarkers of CNS diseases.”
BackgroundInfluentialSelf-citation
Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing
Boland, B., Yu, W. H., Corti, O., Mollereau, B., Henriques, A., Bézard, E., Pastores, G., Rubinsztein, D. C., Nixon, R. A., Duchen, M. R., et al. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.109 · Cited by 566
Cell-cell communication: New insights and clinical implications
Su, J., Song, Y., Zhu, Z., Huang, X., Fan, J., Qiao, J., & Mao, F. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01888-z · Cited by 433
L1CAM is not associated with extracellular vesicles in human cerebrospinal fluid or plasma
Norman, M., Ter‐Ovanesyan, D., Trieu, W., Lazarovits, R., Kowal, E. J. K., Lee, J.-H., Chen‐Plotkin, A. S., Regev, A., Church, G. M., & Walt, D. R. (2021) · Nature Methods · doi:10.1038/s41592-021-01174-8 · Cited by 261
CNS-Derived Blood Exosomes as a Promising Source of Biomarkers: Opportunities and Challenges
Hornung, S., Dutta, S., & Bitan, G. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00038 · Cited by 244
Molecular biomarkers of Alzheimer's disease: progress and prospects
Lashley, T., Schott, J. M., Weston, P. S. J., Murray, C. E., Wellington, H., Keshavan, A., Foti, S. C., Foiani, M. S., Toombs, J., Rohrer, J. D., et al. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.031781 · Cited by 251
Detection of neuron-derived pathological α-synuclein in blood
Kluge, A., Bunk, J., Schaeffer, E., Drobny, A., Xiang, W., Knacke, H., Bub, S., Lückstädt, W., Arnold, P., Lucius, R., et al. (2022) · Brain · doi:10.1093/brain/awac115 · Cited by 230
Updates in Alzheimer's disease: from basic research to diagnosis and therapies
Liu, E., Zhang, Y., & Wang, J. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00432-x · Cited by 241
Development of Novel Therapeutics Targeting the Blood–Brain Barrier: From Barrier to Carrier
Li, J., Zheng, M., Shimoni, O., Banks, W. A., Bush, A. I., Gamble, J. R., & Shi, B. (2021) · Advanced Science · doi:10.1002/advs.202101090 · Cited by 202
Self-citation
Emerging methods in biomarker identification for extracellular vesicle‐based liquid biopsy
Liang, Y., Lehrich, B. M., Zheng, S., & Lu, M. (2021) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12090 · Cited by 201
Neuroimmune Crosstalk through Extracellular Vesicles in Health and Disease
Delpech, J.-C., Herron, S., Botros, M. B., & Ikezu, T. (2019) · Trends in Neurosciences · doi:10.1016/j.tins.2019.02.007 · Cited by 193
Characterization and Biomarker Analyses of Post-COVID-19 Complications and Neurological Manifestations
Sun, B., Tang, N., Peluso, M. J., Iyer, N. S., Torres, L., Donatelli, J. L., Munter, S. E., Nixon, C. C., Rutishauser, R. L., Rodríguez-Barraquer, I., et al. (2021) · Cells · doi:10.3390/cells10020386 · Cited by 190
Detection of Aggregation-Competent Tau in Neuron-Derived Extracellular Vesicles
Guix, F. X., Corbett, G. T., Cha, D., Mustapić, M., Liu, W., Mengel, D., Chen, Z., Aïkawa, E., Young‐Pearse, T. L., Kapogiannis, D., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030663 · Cited by 186
New windows into the brain: Central nervous system-derived extracellular vesicles in blood
Shi, M., Sheng, L., Stewart, T., Zabetian, C. P., & Zhang, J. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.01.005 · Cited by 181
Self-citation
A longitudinal study on α‐synuclein in plasma neuronal exosomes as a biomarker for Parkinson’s disease development and progression
Niu, M., Li, Y., Li, G., Zhou, L., Luo, N., Yao, M., Kang, W., & Liu, J. (2020) · European Journal of Neurology · doi:10.1111/ene.14208 · Cited by 178
Increased DJ-1 and α-Synuclein in Plasma Neural-Derived Exosomes as Potential Markers for Parkinson’s Disease
Zhao, Z., Chen, Z., Zhou, R., Zhang, X., Ye, Q., & Wang, Y. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00438 · Cited by 180
DJ-1 in Parkinson’s Disease: Clinical Insights and Therapeutic Perspectives
Repici, M., & Giorgini, F. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8091377 · Cited by 174
The Evolving Landscape of Exosomes in Neurodegenerative Diseases: Exosomes Characteristics and a Promising Role in Early Diagnosis
Rastogi, S., Sharma, V., Bharti, P. S., Rani, K., Modi, G. P., Nikolajeff, F. K., & Kumar, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22010440 · Cited by 176
Potential Effects of MSC-Derived Exosomes in Neuroplasticity in Alzheimer’s Disease
Reza-Zaldívar, E. E., Hernández-Sapiéns, M. A., Minjarez, B. D., Gutiérrez-Mercado, Y. K., Márquez-Aguirre, A. L., & Canales-Aguirre, A. A. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00317 · Cited by 169
α-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson’s disease from multiple system atrophy
Dutta, S., Hornung, S., Kruayatidee, A., Maina, K. N., Rosario, I. D., Paul, K. C., Wong, D. Y., Folle, A. D., Markovic, D., Palma, J., et al. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02324-0 · Cited by 166
Exosome Determinants of Physiological Aging and Age-Related Neurodegenerative Diseases
D’Anca, M., Fenoglio, C., Serpente, M., Arosio, B., Cesari, M., Scarpini, E. A., & Galimberti, D. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00232 · Cited by 154
Exosomes and stem cells in degenerative disease diagnosis and therapy
Chang, Y.-H., Wu, K.-C., Harn, H.-J., Lin, S.-Z., & Ding, D.-C. (2018) · Cell Transplantation · doi:10.1177/0963689717723636 · Cited by 159
Biomarkers for Alzheimer’s Disease Early Diagnosis
Ausó, E., Gómez‐Vicente, V., & Esquiva, G. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10030114 · Cited by 159
Biomarkers used in Alzheimer’s disease diagnosis, treatment, and prevention
Mahaman, Y. A. R., Embaye, K. S., Huang, F., Li, L., Zhu, F., Wang, J.-Z., Liu, R., Feng, J., & Wang, X. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101544 · Cited by 149
Neurodegenerative Disorders of Alzheimer, Parkinsonism, Amyotrophic Lateral Sclerosis and Multiple Sclerosis: An Early Diagnostic Approach for Precision Treatment
Pathak, N., Vimal, S. K., Tandon, I., Agrawal, L., Cao, H., & Bhattacharyya, S. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00800-w · Cited by 152
Exosomes in Parkinson disease
Pinnell, J. R., Cui, M., & Tieu, K. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15288 · Cited by 146
Exosomes in Parkinson’s Disease
Wu, X., Zheng, T., & Zhang, B. (2016) · Neuroscience Bulletin · doi:10.1007/s12264-016-0092-z · Cited by 136
Blood-based biomarkers for Alzheimer’s disease—An update
Zetterberg, H. (2018) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2018.10.025 · Cited by 128
L1CAM-associated extracellular vesicles: A systematic review of nomenclature, sources, separation, and characterization
Gomes, D., & Witwer, K. W. (2022) · Journal of Extracellular Biology · doi:10.1002/jex2.35 · Cited by 116
Potential Roles of Exosomes in Parkinson’s Disease: From Pathogenesis, Diagnosis, and Treatment to Prognosis
Yu, H., Sun, T., An, J., Wen, L., Liu, F., Bu, Z., Cui, Y., & Feng, J. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00086 · Cited by 130
The potential use of mesenchymal stem cells and their exosomes in Parkinson’s disease treatment
Mosaddeghi-Heris, R., Shirvaliloo, M., Abbaspour‐Aghdam, S., Hazrati, A., Shariati, A., Youshanlouei, H. R., Jadidi‐Niaragh, F., Valizadeh, H., & Ahmadi, M. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03050-4 · Cited by 123
Systems-based proteomics to resolve the biology of Alzheimer’s disease beyond amyloid and tau
Rayaprolu, S., Higginbotham, L., Bagchi, P., Watson, C. M., Zhang, T., Levey, A. I., Rangaraju, S., & Seyfried, N. T. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-020-00840-3 · Cited by 118
Propagation of Tau via Extracellular Vesicles
Pérez, M., Avila, J., & Hernández, F. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00698 · Cited by 118
Tau in the Pathophysiology of Parkinson’s Disease
Pan, L., Meng, L., He, M., & Zhang, Z. (2021) · Journal of Molecular Neuroscience · doi:10.1007/s12031-020-01776-5 · Cited by 110
Extracellular Vesicles in Brain Tumors and Neurodegenerative Diseases
Ciregia, F., Urbani, A., & Palmisano, G. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00276 · Cited by 110
Oligomeric α-Syn and SNARE complex proteins in peripheral extracellular vesicles of neural origin are biomarkers for Parkinson's disease
Agliardi, C., Meloni, M., Guerini, F. R., Zanzottera, M., Bolognesi, E., Baglio, F., & Clerici, M. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105185 · Cited by 109
Reduced oligodendrocyte exosome secretion in multiple system atrophy involves SNARE dysfunction
Yu, Z., Shi, M. Y., Stewart, T., Fernagut, P., Huang, Y. X. R., Tian, C., Dehay, B., Atik, A., Yang, D., Giorgi, F. D., et al. (2020) · Brain · doi:10.1093/brain/awaa110 · Cited by 111
Self-citation
Extracellular Vesicle Biology in Alzheimer’s Disease and Related Tauopathy
DeLeo, A. M., & Ikezu, T. (2017) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-017-9768-z · Cited by 109
Extracellular vesicles in the diagnosis and treatment of central nervous system diseases
Rizvanov, A. A., Shaimardanova, A. A., Solovyeva, V. V., Chulpanova, D. S., James, V. H., & Kitaeva, K. V. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.266908 · Cited by 103
Long Noncoding RNA POU3F3 and α-Synuclein in Plasma L1CAM Exosomes Combined with β-Glucocerebrosidase Activity: Potential Predictors of Parkinson's Disease
Zou, J., Guo, Y., Wei, L., Yu, F. F., Yu, B., & Xu, A. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00842-5 · Cited by 95
From Cerebrospinal Fluid to Blood: The Third Wave of Fluid Biomarkers for Alzheimer’s Disease
Zetterberg, H., & Blennow, K. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-179926 · Cited by 98
The penetration of therapeutics across the blood-brain barrier: Classic case studies and clinical implications
Banks, W. A., Rhea, E. M., Reed, M. J., & Erickson, M. A. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101760 · Cited by 90
Self-citation
A Critical Assessment of Exosomes in the Pathogenesis and Stratification of Parkinson’s Disease
Tofaris, G. K. (2017) · Journal of Parkinson s Disease · doi:10.3233/jpd-171176 · Cited by 90
Mitochondrial Dysfunction and Alpha-Lipoic Acid: Beneficial or Harmful in Alzheimer’s Disease?
dos Santos, S. M., Romeiro, C. F. R., Rodrigues, C. A., Cerqueira, A. R. L., & Monteiro, M. C. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/8409329 · Cited by 92
Biomarker potential of brain‐secreted extracellular vesicles in blood in Alzheimer's disease
Badhwar, A., & Haqqani, A. S. (2020) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1002/dad2.12001 · Cited by 87
Acute sleep loss decreases CSF‐to‐blood clearance of Alzheimer's disease biomarkers
Liu, H., Barthélemy, N. R., Ovod, V., Bollinger, J. G., He, Y., Chahin, S. L., Androff, B., Bateman, R. J., & Lucey, B. P. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.12930 · Cited by 89
A new paradigm for diagnosis of neurodegenerative diseases: peripheral exosomes of brain origin
Younas, N., Flores, L. C. F., Hopfner, F., Höglinger, G. U., & Zerr, I. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00301-5 · Cited by 84
Blood extracellular vesicles carrying synaptic function‐ and brain‐related proteins as potential biomarkers for Alzheimer's disease
Tian, C., Stewart, T., Hong, Z., Guo, Z., Aro, P., Soltys, D., Pan, C., Peskind, E. R., Zabetian, C. P., Shaw, L. M. J., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12723 · Cited by 80
Self-citation
Extracellular Vesicles in Alzheimer’s and Parkinson’s Disease: Small Entities with Large Consequences
Vandendriessche, C., Bruggeman, A., Cauwenberghe, C. V., & Vandenbroucke, R. E. (2020) · Cells · doi:10.3390/cells9112485 · Cited by 75
Extracellular vesicles – propagators of neuropathology and sources of potential biomarkers and therapeutics for neurodegenerative diseases
Vassileff, N., Cheng, L., & Hill, A. F. (2020) · Journal of Cell Science · doi:10.1242/jcs.243139 · Cited by 73
Sphingolipid-Enriched Extracellular Vesicles and Alzheimer’s Disease: A Decade of Research
Dinkins, M. B., Wang, G., & Bieberich, E. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160567 · Cited by 71
Brain‐derived extracellular vesicles: Potential diagnostic biomarkers for central nervous system diseases
Xu, X., Iqbal, Z., Xu, L., Wen, C., Duan, L., Xia, J., Yang, N., Zhang, Y., & Liang, Y. (2024) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13610 · Cited by 68
Tau Proteins Cross the Blood-Brain Barrier
Banks, W. A., Kováč, A., Majerová, P., Bullock, K. M., Shi, M. Y., & Zhang, J. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160542 · Cited by 73
Self-citation
Extracellular Vesicle Biomarkers Reveal Inhibition of Neuroinflammation by Infliximab in Association with Antidepressant Response in Adults with Bipolar Depression
Mansur, R. B., Delgado‐Peraza, F., Subramaniapillai, M., Lee, Y. L., Iacobucci, M., Rodrigues, N. B., Rosenblat, J. D., Brietzke, E. M., Cosgrove, V. E., Kramer, N. E., et al. (2020) · Cells · doi:10.3390/cells9040895 · Cited by 69
Exosomes: a novel therapeutic target for Alzheimer’s disease?
Cai, Z., Ke, Z.-Y., Xiao, M., & Quazi, S. H. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.232490 · Cited by 64
Characterization of tau binding by gosuranemab
Sopko, R., Golonzhka, O., Arndt, J. W., Quan, C., Czerkowicz, J., Cameron, A., Smith, B., Yogapriya, M., Gibbons, G. S., Kim, S., et al. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105120 · Cited by 65
Defining the Teratoma as a Model for Multi-lineage Human Development
McDonald, D., Wu, Y., Dailamy, A., Tat, J., Parekh, U., Zhao, D., Hu, M. Y., Tipps, A. M. P., Zhang, K., & Mali, P. (2020) · Cell · doi:10.1016/j.cell.2020.10.018 · Cited by 60
Applying fluid biomarkers to Alzheimer's disease
Zetterberg, H. (2017) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00007.2017 · Cited by 63
Exosomes in Parkinson’s Disease: Current Perspectives and Future Challenges
Yuan, L., & Li, J. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00469 · Cited by 62
Mass spectrometry: A platform for biomarker discovery and validation for Alzheimer's and Parkinson's diseases
Cilento, E. M., Jin, L., Stewart, T., Shi, M., Sheng, L., & Zhang, J. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14635 · Cited by 60
Self-citation
Ultrasensitive assays for detection of plasma tau and phosphorylated tau 181 in Alzheimer’s disease: a systematic review and meta-analysis
Ding, X., Zhang, S., Jiang, L., Wang, L., Li, T., & Lei, P. (2021) · Translational Neurodegeneration · doi:10.1186/s40035-021-00234-5 · Cited by 61
Impact of aging immune system on neurodegeneration and potential immunotherapies
Liang, Z., Zhao, Y., Ruan, L., Zhu, L., Jin, K., Zhuge, Q., Su, D., & Zhao, Y. L. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.07.006 · Cited by 64
Extracellular vesicles as an emerging tool for the early detection of Alzheimer’s disease
Li, T.-R., Wang, X.-N., Sheng, C., Li, Y.-X., Li, F. Z.-T., Sun, Y., & Han, Y. (2019) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2019.111175 · Cited by 60
Central nervous system-derived extracellular vesicles: the next generation of neural circulating biomarkers?
Bravo-Miana, R. D. C., Arizaga-Echebarria, J. K., & Otaegui, D. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00418-9 · Cited by 63
Exploring brain insulin resistance in adults with bipolar depression using extracellular vesicles of neuronal origin
Mansur, R. B., Delgado‐Peraza, F., Subramaniapillai, M., Lee, Y. L., Iacobucci, M., Nasri, F., Rodrigues, N. B., Rosenblat, J. D., Brietzke, E. M., Cosgrove, V. E., et al. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.12.007 · Cited by 62
Physiological clearance of tau in the periphery and its therapeutic potential for tauopathies
Wang, J., Jin, W., Bu, X., Zeng, F., Huang, Z., Li, W., Shen, L., Zhuang, Z., Fang, Y., Sun, B., et al. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1891-2 · Cited by 62
Identification of exosomal biomarkers and its optimal isolation and detection method for the diagnosis of Parkinson's disease: A systematic review and meta-analysis
Nila, I. S., Sumsuzzman, D. M., Khan, Z. A., Jung, J. H., Kazema, A. S., Kim, S. J., & Hong, Y. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101764 · Cited by 58
Proteomics Profiling of Neuron-Derived Small Extracellular Vesicles from Human Plasma: Enabling Single-Subject Analysis
Anastasi, F., Masciandaro, S. M., Carratore, R. D., Dell’Anno, M. T., Signore, G., Falleni, A., McDonnell, L. A., & Bongioanni, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062951 · Cited by 55
RETRACTED: Decrypting the potential role of α-lipoic acid in Alzheimer's disease
Kaur, D., Behl, T., Sehgal, A., Singh, S., Sharma, N., Chigurupati, S., Alhowail, A., Abdeen, A., Ibrahim, S. F., Vargas-De-La-Cruz, C. B., et al. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119899 · Cited by 57
Retracted
Erythrocytic α-synuclein contained in microvesicles regulates astrocytic glutamate homeostasis: a new perspective on Parkinson’s disease pathogenesis
Sheng, L., Stewart, T., Yang, D., Thorland, E., Soltys, D., Aro, P., Khrisat, T., Xie, Z., Li, N., Liu, Z., et al. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-00983-w · Cited by 56
Self-citation
Blood-Based ATN Biomarkers of Alzheimer’s Disease: A Meta-Analysis
Koychev, I. G., Jansen, K., Dette, A., Shi, L., & Holling, H. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200900 · Cited by 59
Systemic determinants of brain health in ageing
Smith, E. E., Biessels, G. J., Gao, V., Gottesman, R. F., Liesz, A., Parikh, N. S., & Iadecola, C. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-01016-z · Cited by 57
Extracellular vesicles in neurodegenerative diseases: Insights and new perspectives
Yuan, Q., Li, X., Zhang, S.-M., Wang, H., & Wang, Y. (2019) · Genes & Diseases · doi:10.1016/j.gendis.2019.12.001 · Cited by 60
β-Amyloid in blood neuronal-derived extracellular vesicles is elevated in cognitively normal adults at risk of Alzheimer’s disease and predicts cerebral amyloidosis
Li, T., Yao, Y., Jiang, X., Dong, Q., Yu, X., Wang, T., Cai, Y., & Han, Y. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-01010-x · Cited by 52
Oligomeric α-synuclein and tau aggregates in NDEVs differentiate Parkinson's disease from atypical parkinsonisms
Meloni, M., Agliardi, C., Guerini, F. R., Zanzottera, M., Bolognesi, E., Picciolini, S., Marano, M., Magliozzi, A., Fonzo, A. D., Arighi, A., et al. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105947 · Cited by 52
Extracellular Vesicles for the Diagnosis of Parkinson's Disease: Systematic Review and Meta‐Analysis
Xylaki, M., Chopra, A., Weber, S., Bartl, M., Outeiro, T. F., & Mollenhauer, B. (2023) · Movement Disorders · doi:10.1002/mds.29497 · Cited by 53
Emerging Role of Extracellular Vesicles as Biomarkers in Neurodegenerative Diseases and Their Clinical and Therapeutic Potential in Central Nervous System Pathologies
Malaguarnera, M., & Cabrera‐Pastor, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251810068 · Cited by 51
Insights Into the Proteomic Profiling of Extracellular Vesicles for the Identification of Early Biomarkers of Neurodegeneration
Quiroz‐Baez, R., Hernández‐Ortega, K., & Martínez‐Martínez, E. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.580030 · Cited by 52
Analysis of biomarkers in speculative CNS-enriched extracellular vesicles for parkinsonian disorders: a comprehensive systematic review and diagnostic meta-analysis
Taha, H. B., & Bogoniewski, A. (2023) · Journal of Neurology · doi:10.1007/s00415-023-12093-3 · Cited by 49
Brain Exosomes: Friend or Foe in Alzheimer’s Disease?
Kaur, S., Verma, H., Dhiman, M., Tell, G., Gigli, G. L., Janes, F., & Mantha, A. K. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02547-y · Cited by 45
The prion-like transmission of tau oligomers via exosomes
Jackson, N. A., Guerrero‐Munoz, M. J., & Castillo‐Carranza, D. L. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.974414 · Cited by 46
Biomarker and therapeutic potential of peripheral extracellular vesicles in Alzheimer’s disease
Vandendriessche, C., Kapogiannis, D., & Vandenbroucke, R. E. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114486 · Cited by 44
Cerebrospinal fluid α‐synuclein contributes to the differential diagnosis of Alzheimer's disease
Shi, M., Tang, L., Toledo, J. B., Ginghina, C., Wang, H., Aro, P., Jensen, P. H., Weintraub, D., Chen‐Plotkin, A. S., Irwin, D. J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.015 · Cited by 42
Self-citation
Time-dependent cytokine and chemokine changes in mouse cerebral cortex following a mild traumatic brain injury
Tweedie, D., Karnati, H. K., Mullins, R. J., Pick, C. G., Hoffer, B. J., Goetzl, E. J., Kapogiannis, D., & Greig, N. H. (2020) · eLife · doi:10.7554/elife.55827 · Cited by 42
N-Acetyl-Cysteine: Modulating the Cysteine Redox Proteome in Neurodegenerative Diseases
Martínez, M. (2022) · Antioxidants · doi:10.3390/antiox11020416 · Cited by 46
Plasma α-synuclein and cognitive impairment in the Parkinson's Associated Risk Syndrome: A pilot study
Wang, H., Atik, A., Stewart, T., Ginghină, C., Aro, P., Kerr, K. F., Seibyl, J. P., Jennings, D. L., Jensen, P. H., MAREK, K. L., et al. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.04.015 · Cited by 41
Self-citation
Potential of extracellular vesicles in the Parkinson's disease – Pathological mediators and biomarkers
Zhao, Y., & Yang, G. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.104974 · Cited by 41
Biofluid markers of blood-brain barrier disruption and neurodegeneration in Lewy body spectrum diseases: A systematic review and meta-analysis
Wong, Y. Y., Wu, C., Yu, D., Kim, E., Wong, M., Elez, R., Zebarth, J., Ouk, M., Tan, J., Liao, J., et al. (2022) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2022.06.004 · Cited by 41
Extracellular vesicles, new actors in the search for biomarkers of dementias
Gámez‐Valero, A., Beyer, K., & Borràs, F. E. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.10.006 · Cited by 38
A new diagnostic tool for brain disorders: extracellular vesicles derived from neuron, astrocyte, and oligodendrocyte
Wang, X., Yang, H., Liu, C., & Liu, K. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1194210 · Cited by 36
Assessment of brain‐derived extracellular vesicle enrichment for blood biomarker analysis in age‐related neurodegenerative diseases: An international overview
Badhwar, A., Hirschberg, Y., Valle‐Tamayo, N., Iulita, M. F., Udeh‐Momoh, C. T., Matton, A., Tarawneh, R. M., Rissman, R. A., Ledreux, A., Winston, C. N., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13823 · Cited by 34
The molecular tweezer CLR01 improves behavioral deficits and reduces tau pathology in P301S-tau transgenic mice
Di, J., Siddique, I. A., Li, Z., Malki, G. J., Hornung, S., Dutta, S., Hurst, I., Ishaaya, E., Wang, A., Tu, S., et al. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00743-x · Cited by 38
Potential Exosome Biomarkers for Parkinson’s Disease Diagnosis: A Systematic Review and Meta-Analysis
Kim, K. Y., Shin, K. Y., & Chang, K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105307 · Cited by 35
Development of a Sensitive Diagnostic Assay for Parkinson Disease Quantifying α-Synuclein–Containing Extracellular Vesicles
Hong, Z., Tian, C., Stewart, T., Aro, P., Soltys, D., Bercow, M., Sheng, L., Borden, K., Khrisat, T., Pan, C., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000011853 · Cited by 36
Self-citation
Potential Therapeutic Applications and Developments of Exosomes in Parkinson’s Disease
Luo, S., Du, L., & Cui, Y. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00195 · Cited by 34
Exosome-Mediated Genetic Information Transfer, a Missing Piece of Osteoblast–Osteoclast Communication Puzzle
Yin, P., Lv, H., Li, Y., Deng, Y., Zhang, L., & Tang, P. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00336 · Cited by 33
Role of Exosomes in the Pathogenesis and Theranostic of Alzheimer’s Disease and Parkinson’s Disease
He, A., Wang, M., Li, X., Chen, H., Lim, K., Lu, L., & Zhang, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241311054 · Cited by 34
CNS cell-derived exosome signatures as blood-based biomarkers of neurodegenerative diseases
Park, C., Weerakkody, J. S., Schneider, R., Miao, S., & Pitt, D. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1426700 · Cited by 35
Fluorescence-tagged salivary small extracellular vesicles as a nanotool in early diagnosis of Parkinson’s disease
Rastogi, S., Rani, K., Rai, S., Singh, R., Bharti, P. S., Sharma, V., Sahu, J., Kapoor, V., Vishwakarma, P., Garg, S., et al. (2023) · BMC Medicine · doi:10.1186/s12916-023-03031-1 · Cited by 31

Authors: Shi, M., Kovac, A., Korff, A., Cook, T. J., Ginghina, C., Bullock, K. M., Yang, L., Stewart, T., Zheng, D., Aro, P., Atik, A., Kerr, K. F., Zabetian, C. P., Peskind, E. R., Hu, S., Quinn, J. F., Galasko, D. R., Montine, T. J., Banks, W. A., & Zhang, J.
Affiliations: University of Washington (US)
Geriatric Research, Education, and Clinical Center Veterans Affairs Puget Sound Health Care System Seattle WA USA
Department of Pathology University of Washington School of Medicine Seattle WA USA
Oregon Health & Science University (US)
University of California San Diego (US)
Corresponding author: Zhang, Jing
ORCID: Shi, Min
Zheng, Danfeng
Kerr, Kathleen F.
Zabetian, Cyrus P.
Peskind, Elaine R.
Hu, Shu‐Ching
Quinn, Joseph F.
Galasko, Douglas R.
Montine, Thomas J.
Banks, William A.
Zhang, Jing
Venue: Alzheimer's & Dementia
Publisher: Wiley
Published: 2016-05-24
Volume: 12
Issue: 11
Pages: 1125-1131
ISSN: 1552-5260 (ISSN-L)
1552-5279
DOI: 10.1016/j.jalz.2016.04.003
PMC: PMC5107127
OpenAlex: W2398356848
Cited by: 206
References: 29
Citations by year: 2026: 8 · 2025: 15 · 2024: 29 · 2023: 27 · 2022: 29 · 2021: 24 · 2020: 31 · 2019: 16 · 2018: 17 · 2017: 6 · 2016: 4
FWCI: 11.54
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: Alzheimer s & Dementia (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
eScholarship (California Digital Library) (submittedVersion)
Funders: National Institutes of Health (U01 NS082137, P30 ES007033‐6364, R01 AG033398, R01 ES016873, R01 ES019277, R01 NS057567, P50 NS062684‐6221, R21 NS085425, R01 NS065070, P50 AG05131)
Alzheimer's Association (2015‐NIRG‐342009)
U.S. Department of Veterans Affairs
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords: tau protein
MeSH terms: Adult, Aged, Aged, 80 and over, Alzheimer Disease, Animals, Biological Transport, Blood-Brain Barrier, Female, Humans, Male, Mice, Inbred C57BL, Middle Aged, Parkinson Disease, tau Proteins, Mice, Knockout, Neural Cell Adhesion Molecule L1, Exosomes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

CNS tau efflux via exosomes is likely increased in Parkinson's disease but not in Alzheimer's disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks